Evidence map›Paper›PMID 24550400›Full record

ArticleThe Journal of biological chemistry2014

NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.

Chunsik Lee, Anguo Liu, Alba Miranda-Ribera, Sang Won Hyun, Erik P Lillehoj, Alan S Cross, Antonino Passaniti, P Richard Grimm, Bo-Young Kim, Paul A Welling and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. iScience · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sialidase Inhibitors with Different Mechanisms.Journal of medicinal chemistry · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. ST6Gal1: Oncogenic signaling pathways and targets.Frontiers in molecular biosciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Chunsik LeeFrom the Departments of Medicine.
Anguo Liu
Alba Miranda-Ribera
Sang Won Hyun
Erik P Lillehoj
Alan S Cross
Antonino Passaniti
P Richard Grimm
Bo-Young Kim
Paul A Welling
Joseph A Madri
Horace M DeLisser
Simeon E Goldblum
University of Maryland, Baltimore · USUniversity of Pennsylvania · USYale University · US

Funding

Molecular of ROMK Channel FunctionR01DK054231 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Paul A Welling · 1998 to 2026
$7.7M
Polarized Trafficking of K+ Channels in the KidneyR01DK063049 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WELLING, PAUL A · 2003 to 2016
$4.7M
Thrombospondin-1 Opens Endothelial Paracellular Pathway via EGFR/ErbB2 ActivationR01HL084223 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI GOLDBLUM, SIMEON EMANUEL · 2007 to 2011
$1.9M
Transcriptional regulation of tumor growthI01BX002205 · VA · BALTIMORE VA MEDICAL CENTER · PI PASSANITI, ANTONINO · 2014 to 2017
–
NEU1 Sialidase Disrupts CD31-Driven Angiogenesis in Human Lung EndotheliaI01BX002352 · VA · BALTIMORE VA MEDICAL CENTER · PI GOLDBLUM, SIMEON EMANUEL · 2015 to 2018
–
BLRD VA I01 BX002205BLRD VA I01 BX002352NHLBI NIH HHS R01 HL084223NHLBI NIH HHS R01 HL 084223ANIDDK NIH HHS R01 DK054231NIDDK NIH HHS R01 DK063049
6 · The paper itself

Abstract

The highly sialylated vascular endothelial surface undergoes changes in sialylation upon adopting the migratory/angiogenic phenotype. We recently established endothelial cell (EC) expression of NEU1 sialidase (Cross, A. S., Hyun, S. W., Miranda-Ribera, A., Feng, C., Liu, A., Nguyen, C., Zhang, L., Luzina, I. G., Atamas, S. P., Twaddell, W. S., Guang, W., Lillehoj, E. P., Puché, A. C., Huang, W., Wang, L. X., Passaniti, A., and Goldblum, S. E. (2012) NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia. NEU1 restrains endothelial cell migration whereas NEU3 does not. J. Biol. Chem. 287, 15966-15980). We asked whether NEU1 might regulate EC capillary-like tube formation on a Matrigel substrate. In human pulmonary microvascular ECs (HPMECs), prior silencing of NEU1 did not alter tube formation. Infection of HPMECs with increasing multiplicities of infection of an adenovirus encoding for catalytically active WT NEU1 dose-dependently impaired tube formation, whereas overexpression of either a catalytically dead NEU1 mutant, NEU1-G68V, or another human sialidase, NEU3, did not. NEU1 overexpression also diminished EC adhesion to the Matrigel substrate and restrained EC migration in a wounding assay. In HPMECs, the adhesion molecule, CD31, also known as platelet endothelial cell adhesion molecule-1, was sialylated via α2,6-linkages, as shown by Sambucus nigra agglutinin lectin blotting. NEU1 overexpression increased CD31 binding to Arachis hypogaea or peanut agglutinin lectin, indicating CD31 desialylation. In the postconfluent state, when CD31 ectodomains are homophilically engaged, NEU1 was recruited to and desialylated CD31. In postconfluent ECs, CD31 was desialylated compared with subconfluent cells, and prior NEU1 silencing completely protected against CD31 desialylation. Prior CD31 silencing and the use of CD31-null ECs each abrogated the NEU1 inhibitory effect on EC tube formation. Sialyltransferase 6 GAL-I overexpression increased α2,6-linked CD31 sialylation and dose-dependently counteracted NEU1-mediated inhibition of EC tube formation. These combined data indicate that catalytically active NEU1 inhibits in vitro angiogenesis through desialylation of its substrate, CD31.

Indexed as

AnimalsAntigens, CDbeta-D-Galactoside alpha 2-6-SialyltransferaseCapillariesCell AdhesionCell MovementEndothelial CellsHumansLungMiceN-Acetylneuraminic AcidNeovascularization, PhysiologicNeuraminidasePlatelet Endothelial Cell Adhesion Molecule-1Protein TransportSialyltransferasesAntigens, CDbeta-D-Galactoside alpha 2-6-SialyltransferaseN-Acetylneuraminic AcidNEU1 protein, humanNeuraminidasePlatelet Endothelial Cell Adhesion Molecule-1SialyltransferasesST6GAL1 protein, humanAngiogenesisCD31/PECAM-1Endothelial CellGlycobiologyNeuraminidaseSialic AcidSialidaseSialoproteinsSialyltransferase

Identifiers

PMID24550400
PMCPMC3979388
OpenAlexW2014594219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.